Redacted Limiting-Competition-under-SAT DNA Reagents.pdf

CUI//SP-SSEL

Analyzer Lease and Reagents Cost Per Test (CPT)

Control No: 25-MRCO-WEST-258

CUI Version – February 2017

Memorandum for Record – Limiting Competition at or below the Simplified Acquisition Threshold

1. Contracting Activity: Fort Hood Health Contracting Branch, (HdHCB), Fort Hood, Texas, 76544-4752.

2. Description of Action: The Martin Army Community Hospital (MACH), Fort Benning, GA 31905-2102, has a need for the lease of an analyzer and purchase of all reagents to test for Neisseria Gonorrhoeae and Chlamydia Trachomatis.

Nature: ☐ New Requirement ☒ Follow-on Requirement

Contract Vehicle: ☒ Purchase Request Number PR 0012287133

Pricing/Contract Type: ☒ Fixed

Funds: ☒ Other Funds: __DHP_X____ FY: ____FY26___

Name of Proposed Contractor(s) and Address:

Hologic Sales and Service, LLC.

250 Campus Drive Marlborough, Massachusetts, 01752-3020 Cage Code: 5JP89 ATTN: Jennifer Williams, 404-293-5319, jennifer.williams@hologic.com

3. Description of Services or Supplies:

The Martin Army Community Hospital (MACH), Fort Benning, GA 31905-2102, has a need for the lease of an analyzer and purchase of all reagents to test for Neisseria Gonorrhoeae and Chlamydia Trachomatis on a Cost Per Test (CPT) basis.

The testing system uses transcription-mediated deoxyribonucleic acid/ribonucleic acid (DNA/ RNA) amplification Neisseria gonorrhoeae, transcription-mediated DNA/RNA amplification Chlamydia trachomatis, and transcription-mediated DNA/RNA amplification Trichomonas vaginalis analysis. It allows the lab to test in-house and provide a quick result time as Neisseria gonorrhoeae and Chlamydia trachomatis, both cause sterility, blindness, and other major disease complications if treatment is prolonged. If not approved, the laboratory will be unable to provide healthcare providers with timely microbial pathogen identification results.

Estimated Value: The estimated value of this effort is $211,250.00.

Delivery Date: The request is a supply. The analyzer lease cost is incorporated into the cost of the reagents.

FY26 1 October 2025 to 30 September 2026 $105,625.00 mailto:jennifer.williams@hologic.com

FY27 1 October 2026 to 30 September 2027 $105,625.00 Contract total of $211,250.00

The delivery dates for FY26 will be four CLINs of twelve (12) months. One for the analyzer and three (3) for the reagents, one (1) for each reagent. The total for the twelve months will be $105,625.00 from 1 October 2025 to 30 September 2026.

For FY27 it will be the same. Four CLINs of twelve (12) months. One for the analyzer and three

(3) for the reagents, one (1) for each reagent. The total for the twelve months will be the same at $105,625.00 from 1 October 2026 to 30 September 2027 ending on 30 September 2027.

There is no increase in cost between FY26 and FY27

Vendor Name

CAGE

Code

Business Size

Location Point of Contact Capability Assessment

Hologic Sales and Service, LLC.

5JP89 Other Than Small

250 Campus Drive Marlborough, Massachusetts, 01752-3020

Name: Jennifer Williams, 404- 293-5319, jennifer.williams@hologic.com

Manufacturer of the analyzer currently used by the United States Government.

4. Authority:

☒ FAR 13.106-1(b)(1): For purchases not exceeding the simplified acquisition threshold (SAT), only one source reasonably available, urgency, exclusive licensing agreements, brand name, or industrial mobilization.

5. Reasons for Authority Cited:

The testing system uses transcription-mediated DNA/ RNA amplification Neisseria gonorrhoeae, transcription-mediated DNA/RNA amplification Chlamydia trachomatis, and transcription-mediated DNA/RNA amplification Trichomonas vaginalis analysis. It allows the lab to test in-house and provide a quick result time as Neisseria gonorrhoeae and Chlamydia trachomatis, both cause sterility, blindness, and other major disease complications if treatment is prolonged.

If not approved, the laboratory will be unable to provide healthcare providers with timely microbial pathogen identification results.

A sources sought was posted from 2 July 2025 to 9 July 2025. There were no companies on the Interested Vendor List (IVL). Only one response was received via email from the incumbent vendor, Hologic.

mailto:jennifer.williams@hologic.com

The current contract, W91YTZ-20-C-0018, was solicited as full and open competition with only one quote received. The sources sought received only one response and it was from the incumbent.

The previous contract was solicited as full and open competition and only received one quote, the sources sought only received one response from the incumbent, the requested type of tests for Neisseria, Gonorrhoeae, and Chlamydia Trachomatis not being a common test, and no other Government agencies were found for just this type testing.

6. Publicizing Contract Actions: For FAR Part 13 actions, the public display and synopsis requirements of FAR 5.101 and FAR 5.203 ☐ do not apply due to the $ threshold, ☒ apply and will be followed, or ☐ do not apply due to an exception at 5.202 ______________________.

Requirement to post justification in accordance with FAR 8.405-6(b)(3), FAR 13.105(c), or FAR 16.505(a)(4)(iii)(A)

☒ Action is NOT a brand name restriction and is under $250K, no posting required.

7. Market Research: Market research revealed the recommended analyzer is not available on the Government Services Administration (GSA) under the Federal Supply Schedule (FSS).

Email from the company confirmed Hologic has no GSA schedule. A search on GSA for Hologic also confirmed this.

A sources sought was posted from 2 July 2025 to 9 July 2025. There were no companies on the Interested Vendor List (IVL). There was one response via email from the incumbent vendor, Hologic. A search on the new SBA webite at https://search.certifications.sba.gov/ with the NAICS code 325413 and the keyword “DNA” showed two small businesses (SB) with no valid SBA Certifications. One Capabilities Narrative outlined medicinal supplements and the other outline small arms ammunition.

A search for “DNA” in the Paperless Contract Files (PCF) system showed One contract for HPV testing which is different from this and for the previous DNA testing which was solicited. The previously solicited award had only received one quote. The market research results reveal there is not two or more small businesses that can fill this requirement.

This is not a new requirement. The current contract, W91YTZ-20-C-0018, was solicited with only one quote. The sources sought received only one response and it was from the incumbent.

Market research showed it is not available on GSA and not available on SBA. After conducting the market research, the contracting officer determined the recommended source will be used in accordance with FAR § 13.106-1(b)(1), for purchases not exceeding the simplified acquisition threshold (SAT), only one source reasonably available, urgency, exclusive licensing agreements, brand name, or industrial mobilization.

8. Other Facts: N/A

9. Technical/Requirements Certification: I certify that the supporting data under my cognizance which are included in the justification are accurate and complete to the best of my knowledge and belief.

Typed Name: Barbara Nobles Title: Supply Contracting Officer’s Representative (COR) Signature: XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

10. Contracting Officer Certification/Approval:

I hereby determine that the anticipated cost or price to the Government for this contract action will be fair and reasonable based upon price analysis and historical prices paid for same or similar services.

I certify that this justification is accurate and complete to the best of my knowledge and belief, and that completing this purchase as a sole source is in the best interest of the Government.

Additionally, I approve this justification to limit competition subject to the availability of FY26 funds and provided that the services or supplies herein described have otherwise been authorized for acquisition.

Typed Name: FREDICINDA D. JONES Title: Contracting Officer Signature: XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

Contracting Officer Reviewed and Approved 23 July 2025, Fredicinda D. Jones

Controlled by: Army Controlled By: ODASA(P) CUI Category(ies): General Procurement and Acquisition Distribution/Dissemination Control: FED ONLY POC: Clarence C Cude, Jr., 254-553-8440